PROCEPT BioRobotics Corporation Depreciation and Amortization
PROCEPT BioRobotics Corporation (PRCT) reported Depreciation and Amortization of $3.72 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2026-08-05
- PROCEPT BioRobotics Corporation depreciation, depletion and amortization for the quarter ending 2026-06-30 was $1.99M, a 25.25% increase year-over-year.
- PROCEPT BioRobotics Corporation depreciation, depletion and amortization for the quarter ending 2026-03-31 was $1.74M, a 17.63% increase year-over-year.
- PROCEPT BioRobotics Corporation depreciation, depletion and amortization for the quarter ending 2025-12-31 was $1.71M, a 17.62% increase year-over-year.
- PROCEPT BioRobotics Corporation depreciation, depletion and amortization for the quarter ending 2025-09-30 was $1.62M, a 21.84% increase year-over-year.
- PROCEPT BioRobotics Corporation depreciation, depletion and amortization for fiscal 2025 was $6.39M, a 22.09% increase from fiscal 2024.
- PROCEPT BioRobotics Corporation depreciation, depletion and amortization for fiscal 2024 was $5.23M, a 37.48% increase from fiscal 2023.
- PROCEPT BioRobotics Corporation depreciation, depletion and amortization for fiscal 2023 was $3.81M, a 34.00% increase from fiscal 2022.
- PROCEPT BioRobotics Corporation depreciation, depletion and amortization for fiscal 2022 was $2.84M, a 14.53% decline from fiscal 2021.
| Period end | Depreciation, Depletion and Amortization 3 month | Depreciation, Depletion and Amortization 6 month | Depreciation, Depletion and Amortization 9 month | Depreciation, Depletion and Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $3.72M 10-Q · filed 2026-08-05 | $5.43M derived: sum of 3 quarters · filed 2026-08-05 | $7.05M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $1.74M 10-Q · filed 2026-04-30 | $3.44M derived: sum of 2 quarters · filed 2026-04-30 | $5.06M derived: sum of 3 quarters · filed 2026-04-30 | $6.65M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.33M derived: sum of 2 quarters · filed 2026-02-26 | $4.92M derived: sum of 3 quarters · filed 2026-08-05 | $6.39M 10-K · filed 2026-02-26 |
| 2025-09-30 | $1.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $3.21M derived: sum of 2 quarters · filed 2026-08-05 | $4.68M 10-Q · filed 2025-11-05 | $6.13M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $1.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $3.06M 10-Q · filed 2026-08-05 | $4.52M derived: sum of 3 quarters · filed 2026-08-05 | $5.84M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $1.48M 10-Q · filed 2026-04-30 | $2.93M derived: sum of 2 quarters · filed 2026-04-30 | $4.26M derived: sum of 3 quarters · filed 2026-04-30 | $5.53M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.78M derived: sum of 2 quarters · filed 2026-02-26 | $4.05M derived: sum of 3 quarters · filed 2026-02-26 | $5.23M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $2.60M derived: sum of 2 quarters · filed 2025-11-05 | $3.78M 10-Q · filed 2025-11-05 | $5.10M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $2.45M 10-Q · filed 2025-08-07 | $3.77M derived: sum of 3 quarters · filed 2026-02-26 | $4.83M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $1.18M 10-Q · filed 2025-05-02 | $2.50M derived: sum of 2 quarters · filed 2026-02-26 | $3.56M derived: sum of 3 quarters · filed 2026-02-26 | $4.20M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.37M derived: sum of 2 quarters · filed 2026-02-26 | $3.01M derived: sum of 3 quarters · filed 2026-02-26 | $3.81M 10-K · filed 2026-02-26 |
| 2023-09-30 | $1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-28 | $1.70M derived: sum of 2 quarters · filed 2024-10-28 | $2.49M 10-Q · filed 2024-10-28 | $3.15M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $642.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $1.44M 10-Q · filed 2024-08-02 | $2.10M derived: sum of 3 quarters · filed 2025-02-27 | $2.80M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $793.00K 10-Q · filed 2024-05-02 | $1.46M derived: sum of 2 quarters · filed 2025-02-27 | $2.16M derived: sum of 3 quarters · filed 2025-02-27 | $2.88M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $663.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.37M derived: sum of 2 quarters · filed 2025-02-27 | $2.08M derived: sum of 3 quarters · filed 2025-02-27 | $2.84M 10-K · filed 2025-02-27 |
| 2022-09-30 | $703.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $1.42M derived: sum of 2 quarters · filed 2023-11-02 | $2.18M 10-Q · filed 2023-11-02 | $2.94M derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $717.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $1.48M 10-Q · filed 2023-07-28 | $2.24M derived: sum of 3 quarters · filed 2023-07-28 | $3.03M derived: sum of 4 quarters · filed 2023-07-28 |
| 2022-03-31 | $758.00K 10-Q · filed 2023-05-04 | $1.52M derived: sum of 2 quarters · filed 2023-05-04 | $2.32M derived: sum of 3 quarters · filed 2023-05-04 | $3.17M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $763.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $1.56M derived: sum of 2 quarters · filed 2023-02-28 | $2.41M derived: sum of 3 quarters · filed 2023-02-28 | $3.32M 10-K · filed 2023-02-28 |
| 2021-09-30 | $796.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $1.65M derived: sum of 2 quarters · filed 2022-11-04 | $2.56M 10-Q · filed 2022-11-04 | $3.28M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $850.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $1.76M 10-Q · filed 2022-08-05 | $2.48M derived: sum of 3 quarters · filed 2022-08-05 | |
| 2021-03-31 | $915.00K 10-Q · filed 2022-05-06 | $1.63M derived: sum of 2 quarters · filed 2022-05-06 | ||
| 2020-12-31 | $715.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $2.86M 10-K · filed 2022-03-22 | ||
| 2020-09-30 | $2.15M 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |